These include persistent dizziness, confusion, rapid heartbeat, decreased urination, extreme thirst, and dry mucous membranes
Tirzepatide appears to have a greater effect on glycemic control but retatrutide trials are still limited
Patients often lose around 15% of their body weight on Ozempic/Wegovy, while those Mounjaro/Zepbound may see drops of 20% or more
For example, Ozempic is typically administered as a once-weekly injection and comes in pre-set dosages (0.25 mg, 0.5 mg, 1 mg, or 2 mg per week), whereas compounded versions may be customized to different concentrations
Others prefer to inject on an empty stomach
FDA Communications The FDA publishes information about drug applications and approval timelines on its website